Publications by authors named "Keith Stuart"

Claim this Profile
C
Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma.
Andrea Bullock, Keith Stuart, Susanna Jacobus, Thomas Abrams, Raymond Wadlow

J Gastrointest Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer.
Andrew X Zhu, Richard S Finn, Mary Mulcahy, Jayne Gurtler, Weijing Sun, Keith Stuart

Clin Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
Lipika Goyal, Jeffrey G Supko, Jordan Berlin, Lawrence S Blaszkowsky, Amanda Carpenter, Keith E Stuart

Cancer Chemother Pharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor.
Jennifer A Chan, Lawrence Blaszkowsky, Keith Stuart, Andrew X Zhu, Jill Allen

Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.
Jennifer A Chan, Keith Stuart, Craig C Earle, Jeffrey W Clark, Pankaj Bhargava

J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.
Jennifer A Chan, Andrew X Zhu, Keith Stuart, Pankaj Bhargava, Craig C Earle

Cancer Chemother Pharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant and neoadjuvant therapy in curable pancreatic cancer.
F W Nugent, Keith Stuart

Surg Clin North Am· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study.
Andrew X Zhu, Jeffrey A Meyerhardt, Lawrence S Blaszkowsky, Avinash R Kambadakone, Alona Muzikansky, Keith Stuart

Lancet Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic adenocarcinoma in the pregnant patient: a case report and literature review.
Rose M Kakoza, Charles M Vollmer, Keith E Stuart, Tamara Takoudes, Douglas W Hanto

J Gastrointest Surg· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.
Matthew H Kulke, Jason L Hornick, Christine Frauenhoffer, Susanne Hooshmand, David P Ryan, Keith Stuart

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Matthew H Kulke, Heinz-Josef Lenz, Neal J Meropol, James Posey, David P Ryan, Keith Stuart

J Clin Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.
Jeffrey A Meyerhardt, Andrew X Zhu, Keith Stuart, David P Ryan, Lawrence Blaszkowsky

Dig Dis Sci· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
Devon Evans, Thomas Miner, David Iannitti, Paul Akerman, Dennis Cruff, Keith Stuart

Cancer Invest· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.
Andrew X Zhu, Keith Stuart, Lawrence S Blaszkowsky, Alona Muzikansky, Donald P Reitberg

Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-directed therapies for metastatic neuroendocrine tumors.
Crain Garrot, Keith Stuart

Hematol Oncol Clin North Am· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.
Andrew X Zhu, Lawrence S Blaszkowsky, David P Ryan, Jeffrey W Clark, Alona Muzikansky, Keith Stuart

J Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycemia and biliary tract adenocarcinoma.
Daniel B Costa, Keith E Stuart, Silvio E Inzucchi

J Gastroenterol Hepatol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
Matthew H Kulke, Keith Stuart, Peter C Enzinger, David P Ryan, Jeffrey W Clark

J Clin Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.
James Y Tsai, David Iannitti, Anna Berkenblit, Paul Akerman, Ahmed Nadeem, Keith Stuart

Am J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Matthew H Kulke, Haesook Kim, Keith Stuart, Jeffrey W Clark, David P Ryan

Cancer Invest· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous cystic duct stent placement for the treatment of acute cholecystitis resulting from common bile duct stent placement for malignant obstruction.
Robert G Sheiman, Keith Stuart

J Vasc Interv Radiol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.
Robert C Shepard, Donna E Levy, Jordan D Berlin, Keith Stuart, Jules E Harris

Oncology· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of interferon gamma in malignant carcinoid tumors (E9292): a trial of the Eastern Cooperative Oncology Group.
Keith Stuart, Donna E Levy, Tom Anderson, Constantine A Axiotis, Janice P Dutcher

Invest New Drugs· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
Muneeb Ahmed, Wayne E Monsky, Geoffrey Girnun, Anatoly Lukyanov, Giuseppe D'Ippolito, Keith E Stuart

Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.
Pankaj Bhargava, Chirag R Jani, Diane M Savarese, Judith L O'Donnell, Keith E Stuart

Oncology (Williston Park)· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis